Covered recipient · General Payments record
MARGARITA MIKHAYLOVA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$22,174.03
- Reported across 931 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,250.00 | 2 |
| Food and Beverage | $3,971.50 | 212 |
| Education | $16.72 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $6,467.57 | 63 |
| PFIZER INC. | $591.72 | 42 |
| SK Life Science, Inc. | $521.33 | 33 |
| Lilly USA, LLC | $447.13 | 16 |
| EISAI INC. | $245.10 | 12 |
| Lundbeck LLC | $171.12 | 11 |
| TG THERAPEUTICS, INC. | $89.78 | 4 |
| Teva Pharmaceuticals USA, Inc. | $80.61 | 4 |
| Biogen, Inc. | $77.50 | 4 |
| Amgen Inc. | $53.60 | 3 |
| UCB, Inc. | $53.53 | 3 |
| Ipsen Biopharmaceuticals, Inc | $50.35 | 2 |
| SCILEX PHARMACEUTICALS INC. | $48.73 | 2 |
| Celgene Corporation | $40.26 | 2 |
| CSL Behring | $36.91 | 2 |
| ARGENX US, INC. | $34.00 | 1 |
| HARMONY BIOSCIENCES LLC | $29.00 | 1 |
| REVANCE THERAPEUTICS, INC. | $27.62 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $24.06 | 1 |
| Amneal Pharmaceuticals LLC | $23.68 | 1 |
| Merz Pharmaceuticals, LLC | $22.31 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.63 | 1 |
| Acerta Pharma LLC | $20.20 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
| Currax Pharmaceuticals LLC | $15.95 | 1 |
| Averitas Pharma Inc. | $14.67 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (215)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.